These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35389449)

  • 1. Rates of Visual Field Change in Patients With Glaucoma and Healthy Individuals: Findings From a Median 25-Year Follow-up.
    Giammaria S; Hutchison DM; Rafuse PE; Shuba LM; LeBlanc RP; Nicolela MT; Chauhan BC
    JAMA Ophthalmol; 2022 May; 140(5):504-511. PubMed ID: 35389449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Rate of Ganglion Cell Complex Thinning and Rate of Central Visual Field Loss.
    Mahmoudinezhad G; Moghimi S; Nishida T; Latif K; Yamane M; Micheletti E; Mohammadzadeh V; Wu JH; Kamalipour A; Li E; Liebmann JM; Girkin CA; Fazio MA; Zangwill LM; Weinreb RN
    JAMA Ophthalmol; 2023 Jan; 141(1):33-39. PubMed ID: 36416837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Blood Pressure With Rates of Macular Ganglion Cell Complex Thinning in Patients With Glaucoma.
    Mohammadzadeh V; Su E; Mohammadi M; Law SK; Coleman AL; Caprioli J; Weiss RE; Nouri-Mahdavi K
    JAMA Ophthalmol; 2023 Mar; 141(3):251-257. PubMed ID: 36757702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Fast Visual Field Loss With Risk of Falling in Patients With Glaucoma.
    Baig S; Diniz-Filho A; Wu Z; Abe RY; Gracitelli CP; Cabezas E; Medeiros FA
    JAMA Ophthalmol; 2016 Aug; 134(8):880-6. PubMed ID: 27280703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Glaucoma Progression in Individuals of African Descent Compared With Those of European Descent.
    Gracitelli CPB; Zangwill LM; Diniz-Filho A; Abe RY; Girkin CA; Weinreb RN; Liebmann JM; Medeiros FA
    JAMA Ophthalmol; 2018 Apr; 136(4):329-335. PubMed ID: 29450497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual field progression with frequency-doubling matrix perimetry and standard automated perimetry in patients with glaucoma and in healthy controls.
    Redmond T; O'Leary N; Hutchison DM; Nicolela MT; Artes PH; Chauhan BC
    JAMA Ophthalmol; 2013 Dec; 131(12):1565-72. PubMed ID: 24177807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Neurocognitive Decline and Visual Field Variability in Glaucoma.
    Diniz-Filho A; Delano-Wood L; Daga FB; Cronemberger S; Medeiros FA
    JAMA Ophthalmol; 2017 Jul; 135(7):734-739. PubMed ID: 28520873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated Utility of the Short-term Assessment of Glaucoma Progression Model in Clinical Practice.
    Proudfoot JA; Zangwill LM; Moghimi S; Bowd C; Saunders LJ; Hou H; Belghith A; Medeiros FA; Williams-Steppe E; Acera T; Dirkes K; Weinreb R
    JAMA Ophthalmol; 2021 Aug; 139(8):839-846. PubMed ID: 34110362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast Visual Field Progression Is Associated with Depressive Symptoms in Patients with Glaucoma.
    Diniz-Filho A; Abe RY; Cho HJ; Baig S; Gracitelli CP; Medeiros FA
    Ophthalmology; 2016 Apr; 123(4):754-9. PubMed ID: 26920097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual Field Progression in Patients with Primary Angle-Closure Glaucoma Using Pointwise Linear Regression Analysis.
    Verma S; Nongpiur ME; Atalay E; Wei X; Husain R; Goh D; Perera SA; Aung T
    Ophthalmology; 2017 Jul; 124(7):1065-1071. PubMed ID: 28372858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency Doubling Technology Perimetry and Changes in Quality of Life of Glaucoma Patients: A Longitudinal Study.
    Abe RY; Gracitelli CP; Diniz-Filho A; Zangwill LM; Weinreb RN; Medeiros FA
    Am J Ophthalmol; 2015 Jul; 160(1):114-122.e1. PubMed ID: 25868760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glaucomatous Visual Field Progression in the African Descent and Glaucoma Evaluation Study (ADAGES): Eleven Years of Follow-up.
    Melchior B; Valenzuela IA; De Moraes CG; Paula JS; Fazio MA; Girkin CA; Proudfoot J; Cioffi GA; Weinreb RN; Zangwill LM; Liebmann JM
    Am J Ophthalmol; 2022 Jul; 239():122-129. PubMed ID: 35172170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between Longitudinal 10-2 Central Visual Field Change and the Risk of Visual Acuity Loss in Mild-to-Moderate Glaucoma.
    Wu JH; Moghimi S; Nishida T; Kamalipour A; Liebmann JM; Fazio M; Girkin CA; Zangwill LM; Weinreb RN
    J Glaucoma; 2023 Jul; 32(7):549-555. PubMed ID: 37171991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can Home Monitoring Allow Earlier Detection of Rapid Visual Field Progression in Glaucoma?
    Anderson AJ; Bedggood PA; George Kong YX; Martin KR; Vingrys AJ
    Ophthalmology; 2017 Dec; 124(12):1735-1742. PubMed ID: 28764889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of open-angle glaucoma.
    Heijl A; Bengtsson B; Hyman L; Leske MC;
    Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Vision-Related Disability in Glaucoma.
    Abe RY; Diniz-Filho A; Costa VP; Wu Z; Medeiros FA
    Ophthalmology; 2018 Jan; 125(1):22-30. PubMed ID: 29033061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between rates of binocular visual field loss and vision-related quality of life in patients with glaucoma.
    Lisboa R; Chun YS; Zangwill LM; Weinreb RN; Rosen PN; Liebmann JM; Girkin CA; Medeiros FA
    JAMA Ophthalmol; 2013 Apr; 131(4):486-94. PubMed ID: 23450425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Smoking on Visual Field Progression in a Long-term Clinical Follow-up.
    Mahmoudinezhad G; Nishida T; Weinreb RN; Baxter SL; Eslani M; Micheletti E; Liebmann JM; Fazio MA; Girkin CA; Zangwill LM; Moghimi S
    Ophthalmology; 2022 Nov; 129(11):1235-1244. PubMed ID: 35752211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian Glaucoma Study: 3. Impact of risk factors and intraocular pressure reduction on the rates of visual field change.
    Chauhan BC; Mikelberg FS; Artes PH; Balazsi AG; LeBlanc RP; Lesk MR; Nicolela MT; Trope GE;
    Arch Ophthalmol; 2010 Oct; 128(10):1249-55. PubMed ID: 20696979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.